SCHEMBL20722867

SCHEMBL20722867

CC(C)(C)OC(=O)N1CCN(c2cnc3c(c2)CC[C@H](NC(=O)OCc2ccccc2)C3)CC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RORC P51449 5/20 0.47
ACHE P22303 2/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
MAPT P10636 2/20 0.44
MAPK1 P28482 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
NTSR1 P30989 1/20 0.44
GPR119 Q8TDV5 4/20 0.44
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
SYK P43405 1/20 0.43
YAP1 P46937 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30059991 1.00 RORC (0.47) RORCACHECA1CA2L3MBTL1
SCHEMBL20732043 1.00 RORC (0.47) RORCACHECA1CA2L3MBTL1
SCHEMBL20722797 0.90 CA1 (0.48) RORCACHECA1CA2ALDH1A1
SCHEMBL30061708 0.85 RORC (0.47) RORCACHEL3MBTL1MEN1KMT2A
SCHEMBL30059845 0.85 ACHE (0.49) ACHECA1CA2L3MBTL1MEN1
SCHEMBL21685571 0.85 ACHE (0.49) ACHECA1CA2L3MBTL1MEN1
SCHEMBL20722411 0.85 ACHE (0.49) ACHECA1CA2L3MBTL1MEN1
SCHEMBL28576430 0.84 CA1 (0.48) ACHECA1CA2L3MBTL1MEN1
SCHEMBL20722621 0.84 CA1 (0.48) ACHECA1CA2L3MBTL1MEN1
SCHEMBL20722476 0.80 ACHE (0.47) ACHECA1CA2L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3665169-A1 CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS Forma Therapeutics, Inc. (US) 2020-06-17 EP disclosed
WO-2019032863-A1 CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2019-02-14 WO disclosed